wellrank.ai
Sign In
Olumiant logo

Olumiant

First cited by AI Jun 13, 2026

Surfaced organically in AI answers about hair loss treatment. Not yet profiled.

Olumiant is losing the AEO war.

Not cited in a single tracked AI answer since Sep 10, 2026, down from a peak of 3% visibility in hair loss treatment on Jun 13, 2026. This page stays public, and recovery shows here the day it happens.

AI Visibility

Visibility trend

Hair loss treatment, daily share of AI answers mentioning Olumiant, through Sep 11, 2026.

0.0%

Last cited Sep 10, 2026 · peak 3% on Jun 13

By engine

Where Olumiant is strong, and where it is invisible.

  • No engine data yet.

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 4 positive mentions
  • 1 neutral
  • 0 mixed or cautious

Recent AI answers mentioning Olumiant

ChatGPTSep 6, 2026, 14:29 UTC
What is the best hair loss treatment for women?

Short answer: there’s no one “best” universal treatment — the right option depends on the cause. For the most common condition in women (female pattern hair loss, aka androgenetic alopecia) the best-evidenced first-line treatment is topical minoxidil. Other effective options (used alone or combined) include anti-androgen medications, low‑level laser therapy, PRP, and — when medical therapy fails and hair loss is stable — hair transplantation. Practical recommendations (by name) and why: Women’s Rogaine (minoxidil 5% foam) Why: FDA‑approved for female pattern hair loss, strong evidence for slowing loss and stimulating regrowth. Easy topical use and well tolerated. Spironolactone (brand: Aldactone) — prescription oral anti-androgen Why: Often effective for women with signs of excess androgens or poor response to minoxidil. Requires monitoring (blood pressure, potassium) and must not be used in pregnancy. Low-dose oral minoxidil (prescribed off‑label by many dermatologists) Why: Increasing evidence that low daily doses (very small, e.g., 0.25–2.5 mg) can be effective when topical minoxidil isn’t enough. Do this only under dermatologist supervision. Finasteride (brand: Propecia) — usually not first choice in premenopausal women Why: Can work in some women but is less commonly used due to teratogenic risk and variable effectiveness; used carefully in select postmenopausal patients or with strict contraception. Platelet-rich plasma (PRP) therapy (available at many dermatology/plastic surgery clinics) Why: Clinic-based injections that can stimulate regrowth for some women; evidence is mixed but promising as an adjunct. Low-level laser therapy devices (HairMax, Capillus) Why: Home-use laser caps/comb devices have clinical data showing modest improvement; often used together with minoxidil. Hair transplant surgery (FUE) — clinics such as Bosley, Bernstein Medical, and qualified local surgeons Why: Best for women with stable, localized loss who want a surgical solution; requires experienced surgeon and stable donor area. Supplements (Nutrafol Women, Viviscal) Why: Some randomized studies show modest benefit, especially when diet or micronutrient deficiencies are factors. Not a substitute for medical therapy. For alopecia areata (autoimmune patchy loss): baricitinib (Olumiant) is FDA‑approved for severe disease in adults; intralesional or topical steroids are also commonly used. Why: Alopecia areata needs a different approach than pattern hair loss. Important diagnostics and safety notes: Get a medical evaluation first: a dermatologist/trichologist should assess pattern and cause. Tests commonly ordered: ferritin (iron stores — aim for >50–70 ng/mL for hair regrowth), TSH, CBC, pregnancy test if applicable, and androgen levels if you have acne/hirsutism/irregular periods. Pregnancy and breastfeeding: many treatments (finasteride, spironolactone) are contraindicated. Minoxidil topical is typically used with caution; always discuss with your clinician. Side effects and monitoring: spironolactone affects potassium and blood pressure; oral medications require medical follow-up. PRP and laser have lower systemic risk but variable benefit. Next steps I recommend: See a board-certified dermatologist or hair-loss specialist for diagnosis. Get basic labs (TSH, ferritin, pregnancy if applicable, and androgen tests if indicated). Start evidence-based first-line therapy (topical minoxidil/Women’s Rogaine) while you and your clinician consider add-ons (spironolactone, laser, PRP) based on cause and goals. If you want, tell me your age, whether you’re pregnant or planning pregnancy, how the hair is thinning (diffuse vs patches vs frontal), and any other symptoms (irregular periods, acne, recent illness or stress). I can suggest a more tailored next step.

Mentioned in position 9 of 9

Read full answer with sources →
ChatGPTAug 2, 2026, 12:40 UTC
What is the best hair loss treatment for women?

Short answer: there’s no single “best” treatment for every woman — the right therapy depends on the cause. But for the most common cause (female pattern hair loss / androgenetic alopecia) the best-evidenced first-line treatment is topical minoxidil (brand: Rogaine) — often combined with other options (oral anti-androgens, low-level laser, PRP) if needed. See a dermatologist/trichologist to confirm the diagnosis and check labs before starting treatment. Recommended options (how they’re used and why): Topical minoxidil (Rogaine Women’s 5% Foam) Why: Only FDA‑approved topical medication for female pattern hair loss with good evidence for stopping thinning and regrowing some hair. How: Apply once daily to the scalp; expect 3–6 months to see improvement. Notes: Minimal systemic side effects; must be used long term to maintain results. Oral anti-androgen (spironolactone — brand: Aldactone, prescription) Why: Often effective for women with hormonal pattern hair loss or signs of excess androgens (acne, irregular periods); frequently used off‑label. How: Prescribed by a doctor (commonly 50–200 mg/day tailored to the patient). Notes: Not safe in pregnancy; needs monitoring (blood pressure, potassium). Low‑level laser therapy (LLLT) devices — brands: HairMax, Capillus, iRestore Why: FDA‑cleared devices that some studies show can increase hair density when used regularly. How: Home devices or in-clinic caps/hardwear used several times per week. Notes: Best as an adjunct to minoxidil. Platelet‑rich plasma (PRP) therapy (performed at dermatology or specialized hair clinics) Why: Growing evidence it can stimulate hair regrowth for androgenetic alopecia when done by experienced providers. How: Series of injections (often monthly x3, then maintenance). Notes: Results vary, clinics and protocols differ — choose a board‑certified dermatologist or experienced clinic. Treatments for alopecia areata Topical or intralesional corticosteroids (triamcinolone injections) for small patches — done by dermatologists. Oral JAK inhibitors: baricitinib (Olumiant) is FDA‑approved for severe alopecia areata in adults — prescription and monitored therapy. For telogen effluvium (diffuse shedding) Address the trigger (stress, iron deficiency, thyroid disease, postpartum); lab tests (TSH, ferritin, CBC) and treat underlying causes. Nutraceuticals like Nutrafol or Viviscal may help in recovery for some women. Hair transplantation (FUE or FUT) — clinics like Bernstein Medical, Bosley, and other reputable centers Why: Permanent solution for localized, stable hair loss when donor hair is sufficient. Notes: Not ideal for diffuse female thinning without medical stabilization first. What you should do next See a dermatologist or hair specialist for diagnosis (scalp exam, pull test, sometimes scalp biopsy). Get baseline labs (TSH, ferritin, CBC; hormones if suggested) so treatment targets the cause. If it’s female pattern hair loss, consider starting Rogaine Women’s 5% foam and discuss spironolactone with your doctor if hormonal causes are suspected. Expect 3–6 months to see results. If you want in‑clinic options, ask about PRP or low‑level laser; for patchy alopecia areata ask about steroid injections or referral for JAK inhibitor evaluation. Safety notes Minoxidil and LLLT are generally safe; spironolactone and finasteride are contraindicated in pregnancy and require medical supervision. Always discuss medication interactions and monitoring with your clinician. If you tell me how your hair is thinning (diffuse shedding vs a receding/part-thinning pattern vs sudden patches) and whether you’re pregnant/planning pregnancy, I can recommend a more specific next step and help you find a local dermatologist or a vetted clinic.

Mentioned in position 6 of 10

Read full answer with sources →
ChatGPTJul 23, 2026, 09:37 UTC
What is the best hair loss treatment for women?

Short answer: there’s no single “best” treatment for every woman — the right option depends on the cause. For female pattern hair loss (androgenetic alopecia), first-line, evidence‑based treatment is topical minoxidil (Rogaine Women 5% foam). From there, effective alternatives/add‑ons include prescription antiandrogens (spironolactone), low‑level laser devices, PRP, and — for autoimmune alopecia — other medical therapies. See a dermatologist for testing and a tailored plan. What I recommend and why (by condition) 1) Female pattern hair loss (most common) Rogaine Women 5% Foam (topical minoxidil): FDA‑approved for female pattern thinning. It stimulates follicles, is applied daily, and has the best evidence to increase hair count and slow loss. Expect 3–6 months to see improvement. Aldactone (spironolactone): prescription oral antiandrogen used frequently in women with evidence of hormonal contribution. Often added if minoxidil alone is insufficient. Requires medical follow‑up (blood pressure, potassium) and is not safe in pregnancy. Topical finasteride or oral finasteride (Propecia): sometimes used off‑label in selected post‑menopausal women or via compounding pharmacies; finasteride is teratogenic and not usually first choice for premenopausal women. Nutrafol Women and Viviscal (nutraceuticals): some clinical data show modest benefit for strengthening and reducing shedding as adjuncts, especially when stress, nutrition, or hair quality are concerns. 2) Autoimmune alopecia areata Corticosteroid injections (Kenalog) into bald patches — effective for patchy AA. JAK inhibitors: baricitinib (Olumiant) is FDA‑approved for severe alopecia areata in adults. These drugs can work rapidly but have significant risks and require specialist oversight. 3) Telogen effluvium (diffuse shedding after stress, illness, postpartum) Treat the trigger, correct deficiencies (iron, vitamin D), and supportive therapies (minoxidil or Nutrafol may help). This often improves over months once the cause is addressed. 4) Devices and procedures Low‑level laser therapy (LLLT): HairMax, Capillus, iRestore have FDA‑cleared devices; can be helpful as an adjunct and are low risk. Platelet‑rich plasma (PRP): offered by dermatologists and hair centers; evidence supports benefits for some women when done in a series. Hair transplant surgery (Bosley, Bernstein Medical, Hair Club): effective for selected women with stable donor hair and focal thinning; less commonly suitable for diffuse thinning. Important tests and next steps See a board‑certified dermatologist (hair specialist/trichologist) for diagnosis. Common labs to check: TSH, free T4, ferritin (aim for >50 ng/mL for many with thinning), CBC, vitamin D, zinc, and androgens (free testosterone, DHEA‑S) when indicated. Discuss pregnancy plans — many treatments (spironolactone, finasteride, some topical agents) are contraindicated in pregnancy or breastfeeding. Safety and timeframe Minoxidil: topical side effects include scalp irritation; systemic effects are rare. Spironolactone and finasteride: teratogenic or anti‑androgenic — avoid in pregnancy; need medical monitoring. JAK inhibitors and systemic therapies have immunosuppressive and cardiovascular risks — specialist management required. Most treatments take 3–6 months to show benefit; combine approaches when appropriate. If you want, I can: Suggest a stepwise plan based on your age, pregnancy plans, and pattern of hair loss. Help you find a board‑certified dermatologist or hair clinic in your area. Explain how to use Rogaine Women 5% foam and what to expect week‑by‑week.

Mentioned in position 6 of 12

Read full answer with sources →
ChatGPTJul 13, 2026, 09:35 UTC
What is the best hair loss treatment for women?

Short answer: there’s no one “best” treatment for every woman — the right choice depends on the cause. That said, for the very common female pattern hair loss (androgenetic alopecia) the first-line, evidence-backed treatment is topical minoxidil. Other effective options (used alone or together) include prescription anti-androgens, low-dose oral minoxidil, platelet‑rich plasma (PRP), low-level laser therapy, and — for autoimmune hair loss like alopecia areata — targeted drugs such as baricitinib. Below is a practical guide. 1) Start with a correct diagnosis See a board-certified dermatologist (or hair specialist). Hair loss causes include female pattern hair loss (FPHL), telogen effluvium, alopecia areata, scarring alopecias, thyroid disease, iron deficiency, medication-related loss, etc. Treatment depends on cause. Expect basic labs: thyroid function, ferritin (iron), CBC, vitamin D and, if indicated, androgen levels. 2) First-line for female pattern hair loss (most common) Topical minoxidil (FDA-approved): Rogaine for Women 5% foam is the standard, widely available and well-studied. Apply daily; needs 6–12 months to judge effectiveness. Pros: proven to slow loss and regrow some hair. Cons: local irritation, unwanted facial hair in some women. Ketoconazole shampoo (Nizoral 1% or 2%): not a primary therapy but useful as adjunct (reduces inflammation, may help). 3) Prescription oral options (for appropriate patients, under doctor supervision) Spironolactone (Aldactone): a commonly used anti-androgen for women with signs of hormonal hair loss. Can be effective at 50–200 mg/day. Requires contraception if pregnancy possible and periodic monitoring of potassium/blood pressure. Oral finasteride (Propecia) and dutasteride: sometimes used off-label in postmenopausal women or with contraception; finasteride is teratogenic and not generally recommended for women who can become pregnant. Low‑dose oral minoxidil (compounded or prescribed off-label): many dermatologists now prescribe 0.25–2.5 mg daily for women who don’t respond to topical therapy; effective but has systemic side effects (blood pressure changes, hypertrichosis). 4) In-office and device therapies PRP (platelet-rich plasma) injections: performed in dermatology/hair clinics; many studies show improvement in density for FPHL. Look for reputable clinics with experienced physicians (e.g., dermatology or hair restoration centers). Low-level laser therapy (LLLT) devices: FDA-cleared options include HairMax, Capillus and Theradome. Can be used at home as adjunct; evidence supports modest benefit. Hair transplant surgery (FUE/FUT): effective for localized permanent loss but suitability for women is variable (diffuse thinning may not be ideal). Reputable clinics: Bernstein Medical, Hasson & Wong, Bosley (consult and evaluate candidacy). 5) Autoimmune hair loss (alopecia areata) For patchy or extensive alopecia areata, therapies differ: topical/intralesional steroids for patches; systemic JAK inhibitors are now available — baricitinib (Olumiant) is FDA-approved for severe alopecia areata in adults. Tofacitinib and ruxolitinib are other options used off‑label. Management should be by a dermatologist. 6) What to expect and safety Most treatments take months to show results (minoxidil 3–6 months for shedding to slow; 6–12 months for visible regrowth). Discuss pregnancy plans before starting anti-androgens, finasteride, or systemic drugs. Monitor labs where required (spironolactone, oral minoxidil, etc.). Don’t start prescription meds without a medical evaluation. Practical next steps Book a visit with a board-certified dermatologist who treats hair loss. If you want clinics/brands: try a dermatologist at a recognized hair center (Bernstein Medical, Bosley, or a local academic dermatology clinic). For at-home adjuncts: Rogaine Women 5% foam, Nizoral shampoo, and HairMax or Capillus LLLT devices are commonly used. Bring photos of hairline/part, note timing/triggers (stress, childbirth, medications), and any menstrual/medical history. If you want, tell me: 1) how your hair is thinning (diffuse, widening part, patches), 2) any medical history or medications, and I’ll suggest a more tailored plan and what tests to ask your clinician for.

Mentioned in position 9 of 9

Read full answer with sources →
ChatGPTJun 13, 2026, 11:03 UTC
What is the best hair loss treatment for women?

Short answer: there’s no single “best” treatment for all women — the right option depends on the cause. For the most common problem (female pattern hair loss / androgenetic alopecia), first‑line, evidence‑based choices are topical minoxidil and anti‑androgen therapy; other effective options include PRP, low‑level laser therapy, and (for select patients) hair transplant. For alopecia areata, the newly approved JAK inhibitor baricitinib (Olumiant) and steroid injections are options. Practical, named recommendations and why they’re used Rogaine (minoxidil) Women’s 5% Foam — FDA‑approved for female pattern hair loss; improves hair density and is the usual first‑line topical treatment. It’s easy to use at home; expect 3–6 months to see results. Spironolactone (brand: Aldactone) — an oral anti‑androgen commonly prescribed off‑label for women with androgenetic hair loss or PCOS‑related hair thinning. Often effective for slowing loss and regrowing hair in androgen‑driven cases. Requires medical supervision (blood pressure, potassium, pregnancy avoidance). Low‑dose oral minoxidil (off‑label; prescribed by dermatologists) — many dermatologists now use 0.25–2.5 mg nightly when topical minoxidil isn’t sufficient. Can be very effective but needs monitoring (blood pressure, side effects). Platelet‑Rich Plasma (PRP) at a board‑certified dermatologist’s office — an in‑office procedure with growing evidence for improving hair thickness; often used as an adjunct to medical therapy. Quality varies by clinic, so choose a reputable, experienced provider. Low‑level laser devices (brands: HairMax, LaserCap) — home devices with clinical studies showing modest improvement in hair density; good adjunct or for patients wanting a non‑drug option. Hair transplant (FUE) at established clinics (examples: Bernstein Medical, reputable local hair transplant centers) — effective for stable, advanced pattern hair loss when medical treatments are insufficient. Requires skilled surgeon and realistic expectations. For alopecia areata: Olumiant (baricitinib) — FDA‑approved for severe alopecia areata in adults; intralesional corticosteroid injections are also standard and often effective for patchy disease. Supplements: Nutrafol and Viviscal — some women report benefit; evidence is mixed but they can help when nutritional deficiencies are contributing. Always check iron, vitamin D, B12 first. Important safety and diagnostic notes Get a proper diagnosis first — causes include androgenetic alopecia, telogen effluvium (stress, meds, childbirth), alopecia areata, thyroid disease, iron deficiency, and more. Tests commonly ordered: TSH, ferritin, CBC, and hormone testing if signs of PCOS. Avoid teratogenic medications (finasteride/Propecia is contraindicated in women who may become pregnant). Spironolactone and some oral meds require reliable contraception. Work with a board‑certified dermatologist or hair specialist (trichologist supervised by a dermatologist) for prescriptions, injections, PRP, or transplants. Suggested next steps Book an appointment with a dermatologist experienced in hair loss (in person or via reputable telederm). Get basic labs (TSH, ferritin, CBC; others as suggested). If you have female pattern hair loss, start topical minoxidil (Rogaine Women 5% Foam) and discuss spironolactone or low‑dose oral minoxidil if needed. Consider adjunct PRP or a laser device (HairMax/LaserCap) if you want non‑surgical enhancement. For rapid or patchy loss, ask about alopecia areata management (steroid injections, and for severe cases, Olumiant). If you tell me a bit about your symptoms (pattern of loss, how long, any recent stress/illness, age, pregnancy plans), I can suggest the most likely next step and what tests to ask your doctor for.

Mentioned in position 6 of 8

Read full answer with sources →

TL;DR

Olumiant (baricitinib) is a prescription medication developed by Eli Lilly and Incyte, originally approved for rheumatoid arthritis and later granted FDA approval for alopecia areata, making it the first systemic oral treatment for that condition. It is a JAK inhibitor available through licensed healthcare providers rather than direct-to-consumer channels. In WellRank's latest AI-answer index, Olumiant ranks tenth in the hair loss treatment category with 8% visibility, and the single AI mention captured in our corpus carries a positive tone.

Company Overview

Olumiant is a branded prescription drug co-developed by Eli Lilly and Incyte Corporation. The business model is pharmaceutical: the drug is manufactured and distributed through Eli Lilly, prescribed by dermatologists and rheumatologists, and dispensed via licensed pharmacies. It is not a telehealth platform itself, but it surfaces in telehealth and AI health-answer contexts as a treatment option discussed or prescribed through virtual care visits.

Product Features

  • Baricitinib 2 mg oral tablet for rheumatoid arthritis
  • Baricitinib 4 mg oral tablet approved for severe alopecia areata in adults
  • JAK1 and JAK2 inhibitor mechanism targeting inflammatory pathways
  • Once-daily oral dosing, distinguishing it from topical hair loss treatments
  • FDA Breakthrough Therapy designation history for alopecia areata indication
  • Studied and used in additional indications including COVID-19 hospitalized patients

Target Market

Olumiant is prescribed to adults with moderate-to-severe rheumatoid arthritis and adults with severe alopecia areata. For hair loss, it targets patients who have not responded adequately to other therapies. It is approved and primarily marketed in the United States, European Union, and other major markets worldwide.

Buyer Personas

  • An adult with severe alopecia areata who has tried topical minoxidil and other options without meaningful regrowth and is seeking an oral systemic treatment.
  • A rheumatoid arthritis patient whose disease is not adequately controlled on methotrexate or biologics and who needs an oral JAK inhibitor alternative.
  • A dermatologist or rheumatologist evaluating newer prescription options to discuss with patients during in-person or telehealth consultations.
  • A telehealth platform clinician looking to understand FDA-approved systemic treatments to include in a comprehensive hair loss care pathway.

Funding & Performance

Olumiant is a product of Eli Lilly and Company, a publicly traded global pharmaceutical corporation (NYSE: LLY). Revenue figures specific to Olumiant are reported in Lilly's quarterly earnings disclosures but are not broken out in detail here. Incyte receives royalties under their collaboration agreement.

Recent Developments

The FDA approval of baricitinib for severe alopecia areata marked a significant milestone as the first oral systemic therapy approved specifically for that condition, drawing considerable attention from dermatology and telehealth communities. Eli Lilly has continued to study baricitinib across other inflammatory and immune-mediated conditions. The alopecia areata approval has led to growing discussion of the drug in hair loss treatment contexts, which is reflected in its organic appearance in AI-generated health answers.

Competitive Landscape

In WellRank's co-mention data, Olumiant appears alongside Rogaine, Viviscal, Nutrafol, LaserCap, HairMax, Bernstein Medical, and Aldactone in AI answers about hair loss treatment. Most of those co-mentioned brands are over-the-counter supplements, topical treatments, or devices, while Aldactone (spironolactone) and Olumiant are prescription systemic options, placing Olumiant in a distinct tier. Its once-daily oral mechanism and FDA-approval status for alopecia areata differentiate it clearly from topical or nutraceutical competitors in that set.

Olumiant vs the brands AI recommends alongside it

The real competitive set in Hair loss treatment: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
Olumiant logo
OlumiantThis brand
0.0%
Bernstein Medical logo
Bernstein Medical

5 shared answers

#29
4.4%
HairMax logo
HairMax

5 shared answers

#8
28.9%
Aldactone logo
Aldactone

4 shared answers

#62
2.2%
Bosley logo
Bosley

4 shared answers

#13
17.8%

Email me when overtakes Olumiant

One email the day the ranks flip. Nothing else.

User Sentiment

Based on WellRank's current corpus, Olumiant's single captured AI mention carries a positive tone, with no neutral or cautious mentions recorded at this time. Broader public and clinical sentiment tends to reflect cautious optimism: patients and dermatologists recognize its novel mechanism and demonstrated efficacy in clinical trials for alopecia areata, while also noting the safety monitoring requirements typical of JAK inhibitors. The drug's prescription-only status means most consumer discussion occurs in clinical or patient-advocacy contexts rather than general wellness forums.

Pricing

Olumiant is a branded prescription medication and its list price is set by Eli Lilly; exact out-of-pocket costs vary significantly depending on insurance coverage, pharmacy benefits, and any applicable patient assistance programs offered by the manufacturer. Pricing is not published as a single stable figure and patients are generally directed to their pharmacy or insurer for cost details.

Sources cited around Olumiant

The sites engines cite in answers mentioning this brand. Win these, win the answer.

    Track Olumiant weekly

    One email a week: rank moves, new competitors, and the answers that changed. No noise.

    Work at Olumiant? Get your AI Visibility Audit.

    See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.